ANLN, an onco-gene to code actin-binding protein in tumorigenesis, has been found to up-regulate in rang of human cancers, such as lung adenocarcinoma [44], nasopharyngeal carcinoma [43], cervical cancer [48], breast cancer [45, 49] and colorectal cancer [47]. This evidence concerns the gene ANLN and cancer.